Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes

Rebekka Vibjerg Jensen1, Jesper Møller Jensen1, Nadia Iraqi1

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

PubMed

Insights

Coronary CT angiography (cCTA) is a safe and feasible alternative to invasive coronary angiography (ICA) for assessing coronary artery disease (CAD) in transcatheter aortic valve implantation (TAVI) candidates, showing similar outcomes.

Area of Science:

  • Cardiology
  • Radiology
  • Interventional Cardiology

Background:

  • Concomitant coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve implantation (TAVI).
  • Current guidelines recommend invasive coronary angiography (ICA) for CAD assessment before TAVI, but its prognostic value and the benefits of revascularization remain uncertain.
  • The optimal diagnostic strategy for coronary assessment in TAVI candidates requires further investigation.

Purpose of the Study:

  • To evaluate the feasibility, safety, and clinical outcomes of using cardiac CT angiography (cCTA) as the primary imaging modality for coronary assessment in TAVI candidates.
  • To compare outcomes between patients assessed with cCTA alone versus those who underwent subsequent ICA.

Main Methods:

  • A single-center observational cohort study included 240 TAVI candidates between April 2020 and November 2021.
  • Coronary artery disease was initially assessed by cCTA. Patients with significant proximal or left main stenosis, or non-evaluable cCTA, proceeded to ICA.
  • Outcomes including procedural complications and mortality were compared between groups.

Main Results:

  • 92% of patients demonstrated atherosclerosis on cCTA.
  • 80% of patients (n=191) were assessed by cCTA only, while 20% (n=49) underwent subsequent ICA.
  • Median follow-up was 15 months, with no significant differences in procedural complications, mortality, or unplanned ICAs between the cCTA-only and cCTA+ICA groups.

Conclusions:

  • Upfront cCTA is a feasible and safe strategy for evaluating obstructive CAD in severe aortic stenosis patients referred for TAVI.
  • This approach yields similar procedural and clinical outcomes compared to strategies involving upfront ICA.
  • Further randomized trials are needed to confirm the safety and efficacy of cCTA over ICA for coronary assessment in TAVI candidates.
Abstract